The umbilical cord-blood (UCB) banking market is estimated at USD 17.15 billion in 2018 and is expected to grow at a CAGR of 6.1% from 2018 to 2023, to reach USD 23.06 billion by 2023. UCB is obtained and collected from the umbilical cord of a newborn and also retrieved from the placenta after delivery. UCB contains adult stem cells and these stem cells are essential in regulating various biological activities. Globally, UCB banking market is growing extensively owing to increasing prevalence and incidence rate of chronic diseases coupled with the regenerative medicines.
North America accounted for the largest market for UCB banking in 2017. The US, followed by Canada, is the largest market for UCB banking in the region. Europe accounted for the second largest market and Asia-pacific expected to grow at the fastest growth rate.
Major players operating in this segment include Cord Blood Registry Systems (US), ATCC (US), CORDLIFE GROUP (Singapore), Cord Blood America (US), Caladrius Biosciences (US) Cryo-Cell International (US), ViaCord (US), Esperite N.V. (The Netherlands), Smart Cells International (UK) and China Cord Blood Corporation (China).
This research report covers the global UBC banking market; end user; and geography.
Table of Contents
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
5.2 Market Dynamics
6 Umbilical Cord Blood Banking Market, By Service Type
6.2 Sample Preservation and Storage
6.3 Sample Analysis
6.4 Sample Processing
6.5 Sample Collection and Transportation
7 Umbilical Cord Blood Banking Market, By Application
7.3 Bone Marrow Failure Syndrome
7.4 Metabolic Disorder
7.6 Immune Deficiencies
8 Umbilical Cord Blood Banking Market, By Storage Option
8.2 Public UCB Banks
8.3 Private UCB Banks
9 Umbilical Cord Blood Banking Market, By Region
9.2 North America
9.3.4 Rest of Europe (RoE)
9.5 Rest of the World (RoW)
10 Competitive Landscape
10.2 Market Share Analysis
10.3 Competitive Situation and Trends
10.3.1 Agreements & Partnerships
10.3.4 New Product Launches
10.3.5 Other Developments
11 Compny Profiles
11.2 Cord Blood Registry Systems, Inc.
11.4 Cordlife Group Limited.
11.5 Cord Blood America, Inc.
11.6 Neostem Inc.
11.7 Cryo-Cell International, Inc.
11.9 Esperite Nv.
11.10 Smart Cells International Ltd.
11.11 China Cord Blood Corporation.
1 Above Segmentation May Change During the Course of Planned Research Work.
2 Financials, Recent Developments Might Not Be Captured in Case of Unlisted Companies.
3 Above List of Companies is Tentative. It May Change During the Planned Research Work. However, We Will Profile Only 10 Companies.